UiPath (NYSE:PATH) Price Target Cut to $11.00 by Analysts at Mizuho

UiPath (NYSE:PATH) had its price objective cut by Mizuho from $12.00 to $11.00 in a research report sent to investors on Tuesday morning,Benzinga reports. They currently have a neutral rating on the stock.

Several other analysts also recently commented on PATH. Evercore ISI reduced their price target on shares of UiPath from $16.00 to $12.00 and set an “in-line” rating for the company in a research report on Thursday, March 13th. Needham & Company LLC reiterated a “hold” rating on shares of UiPath in a research note on Wednesday, March 26th. Wells Fargo & Company lowered their price target on UiPath from $13.00 to $11.00 and set an “equal weight” rating on the stock in a report on Thursday, March 13th. Barclays reduced their price objective on UiPath from $15.00 to $12.00 and set an “equal weight” rating for the company in a research note on Thursday, March 13th. Finally, UBS Group decreased their price objective on UiPath from $14.00 to $10.00 and set a “sell” rating for the company in a research report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, UiPath presently has a consensus rating of “Hold” and an average price target of $12.72.

UiPath Stock Down 1.1 %

PATH opened at $10.59 on Tuesday. UiPath has a 52 week low of $9.38 and a 52 week high of $20.95. The business’s 50 day moving average is $11.87 and its two-hundred day moving average is $12.84. The firm has a market cap of $5.84 billion, a price-to-earnings ratio of -66.20 and a beta of 1.04.

Insider Activity at UiPath

In related news, CAO Hitesh Ramani sold 12,500 shares of the company’s stock in a transaction that occurred on Thursday, April 3rd. The stock was sold at an average price of $10.19, for a total value of $127,375.00. Following the sale, the chief accounting officer now owns 314,891 shares in the company, valued at $3,208,739.29. This represents a 3.82 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 22.37% of the company’s stock.

Institutional Trading of UiPath

A number of institutional investors have recently bought and sold shares of PATH. CIBC Asset Management Inc boosted its position in shares of UiPath by 5.3% in the 4th quarter. CIBC Asset Management Inc now owns 14,741 shares of the company’s stock worth $187,000 after buying an additional 736 shares in the last quarter. V Square Quantitative Management LLC lifted its holdings in shares of UiPath by 33.4% in the fourth quarter. V Square Quantitative Management LLC now owns 3,030 shares of the company’s stock valued at $39,000 after purchasing an additional 759 shares in the last quarter. Tidal Investments LLC grew its position in shares of UiPath by 3.7% in the fourth quarter. Tidal Investments LLC now owns 22,487 shares of the company’s stock valued at $286,000 after purchasing an additional 797 shares during the last quarter. True Wealth Design LLC increased its stake in shares of UiPath by 18.4% during the 4th quarter. True Wealth Design LLC now owns 5,163 shares of the company’s stock worth $66,000 after purchasing an additional 801 shares in the last quarter. Finally, First Horizon Advisors Inc. raised its position in shares of UiPath by 47.8% during the 4th quarter. First Horizon Advisors Inc. now owns 2,487 shares of the company’s stock worth $32,000 after purchasing an additional 804 shares during the last quarter. 62.50% of the stock is currently owned by hedge funds and other institutional investors.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.